Skip to main content
Clinical Trials/NCT03554811
NCT03554811
Unknown
Not Applicable

Early Rehabilitation Using Functional Electrical Stimulation Assisted Supine Cycling Effect on Muscle Mass, Strength, Biomarkers, and Functional Outcomes as Compared With Conventional Exercise and Early Mobilization Alone in Critically Ill Patients in the Intensive Care Unit

Fresno Community Hospital and Medical Center1 site in 1 country32 target enrollmentJanuary 1, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
ICU Acquired Weakness
Sponsor
Fresno Community Hospital and Medical Center
Enrollment
32
Locations
1
Primary Endpoint
Percent change of rectus femoris cross-sectional area
Last Updated
4 years ago

Overview

Brief Summary

Critically ill patients in the intensive care unit are known to lose muscle mass and function at a rapid rate. Currently, there is a global recognition and shift in the ICU culture to reduce sedation and encourage exercise and mobilization early during the ICU stay. Functional stimulation assisted supine cycling can be applied to patients in the bed and does not require patient participation. This study seeks to evaluate the effect of conventional exercise and early mobilization in combination with functional stimulation assisted supine cycling applied early during the ICU on muscle mass, strength, and physical function, as well as patient-reported disability as compared to conventional exercise and early mobilization alone.

Registry
clinicaltrials.gov
Start Date
January 1, 2020
End Date
December 31, 2023
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • ≥ 18 years of age
  • Admitted to the ICU with a predicted ICU length of stay ≥ 4 days
  • Expected to survive the ICU stay
  • Expected to receive mechanical ventilation \> 48 hours
  • Able to perform physical outcome measures pre-morbidly (with or without an assisted device)

Exclusion Criteria

  • Proven or suspected neuromuscular weakness affecting the legs (eg- stroke or Guillain-Barré syndrome)
  • Lower limb amputation(s)
  • Assessed by medical staff as approaching imminent death or withdrawal of medical treatment within 36 hours
  • Pregnancy
  • Body mass index \> 40
  • Presence of external fixator or superficial metal in lower limb
  • Open wounds or skin abrasions at electrode application points
  • Presence of pacemaker or implanted defibrillator
  • Transferred from another ICU after \>48 hours of consecutive mechanical ventilation
  • Lower limb malignancy

Outcomes

Primary Outcomes

Percent change of rectus femoris cross-sectional area

Time Frame: Baseline (within 24 hours of enrollment), weekly during ICU admission (up to a maximum of 28 days), at ICU discharge (an average of 11 days after admission), and at hospital discharge (an average of 15 days after admission)

Ultrasound measurements will be done with patients in supine position with their leg in passive extension and neutral rotation.

Secondary Outcomes

  • Quality of life(At hospital discharge (an average of 15 days after admission), and 90 days, 6 months, and 1 year post ICU discharge)
  • Duration of mechanical ventilation(Through discontinuation of mechanical ventilation, an average of 10 days)
  • Physical function(Baseline (within 24 hours of enrollment), weekly during ICU admission (up to a maximum of 28 days), at ICU discharge (an average of 11 days after admission), and at hospital discharge (an average of 15 days after admission))
  • Muscle strength(Baseline (within 24 hours of enrollment), weekly in the ICU (up to a maximum of 28 days), at ICU and hospital discharge (an average of 11 and 15 days after admission, respectively), and at 90 days, 6 months, and 1 year post ICU discharge)
  • Cognition(At hospital discharge (an average of 15 days after admission))
  • Hospital length of stay(Through hospital discharge, an average of 15 days)
  • ICU length of stay(Through ICU discharge, an average of 11 days)
  • Diaphragm muscle thickness(Baseline (within 24 hours of enrollment), weekly in the ICU (up to a maximum of 28 days), at ICU discharge (an average of 11 days after admission), and at hospital discharge (an average of 15 days after admission))

Study Sites (1)

Loading locations...

Similar Trials